Lisata Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
LSTA Nasdaq 2830 www.lisata.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lisata Therapeutics, Inc.

Lisata adds biopharma finance veteran Jeffrey Farrow to board - Oct 15th, 2026 6:41 am
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors - Oct 14th, 2026 2:05 pm
Lisata Therapeutics wins new US patent for pancreatic cancer drug - Oct 8th, 2026 7:10 am
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors - Oct 8th, 2026 6:00 am
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial - Oct 5th, 2026 7:43 am
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly - Oct 5th, 2026 6:00 am
MARKETS LIVE: Nasdaq hits record high as tech stocks lead Wall Street higher - Oct 5th, 2026 5:03 am
Lisata subsidiary Marea Therapeutics gets late-breaking slot at AHA Scientific Sessions - Sep 24th, 2026 6:55 am
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026 - Sep 24th, 2026 6:00 am
MARKETS LIVE: Wall Street ends mixed as Hormuz hopes ease Middle East jitters - Sep 24th, 2026 5:15 am
Lisata Therapeutics (LSTA) Buys Marea and Signs $225M Financing. Is the Dilution Worth it? - Sep 22nd, 2026 6:08 pm
Lisata deal propels Marea’s drug pipeline to Wall Street - Sep 17th, 2026 3:39 pm
Lisata Therapeutics acquires Marea Therapeutics, secures $225 million private placement - Sep 17th, 2026 8:15 am
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement - Sep 17th, 2026 7:26 am
Lisata Therapeutics moves forward with legal action following Kuva merger termination - Aug 4th, 2026 6:48 am
Lisata Therapeutics Provides Update Following Termination of Merger Agreement - Aug 4th, 2026 5:00 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jul 24th, 2026 1:35 pm
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share - Jun 10th, 2026 7:36 am
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. - Jun 10th, 2026 6:00 am
Lisata Therapeutics shares up 20% as Kuva Labs acquisition advances - Mar 9th, 2026 8:29 am